Black Diamond Therapeutics, Inc.
BDTX
$2.83
-$0.01-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.44% | 45.38% | 46.95% | 410.24% | 17.64% |
| Total Depreciation and Amortization | -22.35% | 0.00% | 0.00% | 1.16% | -1.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 456.95% | 33.79% | -56.54% | 35.26% | 15.27% |
| Change in Net Operating Assets | -21.08% | -167.65% | -470.97% | -15.12% | -120.79% |
| Cash from Operations | 54.92% | 30.67% | 37.80% | 351.95% | -7.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -62.50% | -97.92% | -73.68% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -110.42% | 300.42% | -8,527.78% | 162.14% | 126.64% |
| Cash from Investing | -110.40% | 291.70% | -8,093.65% | 162.23% | 126.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -99.23% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -167.35% | 153.17% | -100.54% | -99.23% | 732.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -175.91% | 109.32% | -1,025.70% | 301.24% | 841.87% |